Home Newsfeeds Barclays Maintains Overweight on Solid Biosciences, Raises Price Target to $8

Barclays Maintains Overweight on Solid Biosciences, Raises Price Target to $8

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $2 to $8.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $2 to $8.

Barclays Maintains Underweight on DISH Network, Lowers Price Target to $14

By Benzinga Newsdesk

February 24, 7:44 AM

Barclays analyst Kannan Venkateshwar maintains DISH Network (NASDAQ:DISH) with a Underweight and lowers the price target from $16 to $14.

DISH

This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

By Avi Kapoor

June 14, 9:59 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

BAC

News

Why Taiwan Semiconductor Manufacturing Company Shares Are Falling

By Henry Khederian

April 21, 3:43 PM

Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) shares are trading lower by 4.37% to $85.39 going into the close of Friday's session. The stock may also be pulling back after recent strength and be under pressure amid China-Taiwan tensions. What Else Is Going On In Asia?

TSM

GM’s Total EV Sales In Q1 Can’t Even Match Tesla’s High-End Deliveries

By Anan Ashraf

April 3, 2:24 AM

General Motors sold 16,425 electric vehicles in the U.S. in the first three months of 2024, marking a drop of 20.5% year-on-year.

Barclays Maintains Overweight on Solid Biosciences, Raises Price Target to $8

Related Posts

Barclays Maintains Underweight on DISH Network, Lowers Price Target to $14

This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Why Taiwan Semiconductor Manufacturing Company Shares Are Falling

GM’s Total EV Sales In Q1 Can’t Even Match Tesla’s High-End Deliveries